Features
Everest Medicines targets global expansion with proprietary, AI-driven mRNA platform
The Hong Kong-listed firm is advancing its pipeline using an mRNA system it says can compete with the industry’s best.
tklin@kr-asia.com
Features
The Hong Kong-listed firm is advancing its pipeline using an mRNA system it says can compete with the industry’s best.